D

MADRID—Spanish officials have begun work on a first-ever National Plan for Scientific Research and Development that is meant to rationalize and invigorate the country's entire research program. Cell biologist Emiio Mufioz has been chosen to lead the effort, which stems from a law passed last year to promote and coordinate the country's R&D efforts. But Mufioz, who has overseen science policy for the Socialist government since it came to power in 1982, faces major obstacles to his goal of

Written byMagdalena Ruiz De Elvira
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Cell biologist Emiio Mufioz has been chosen to lead the effort, which stems from a law passed last year to promote and coordinate the country's R&D efforts. But Mufioz, who has overseen science policy for the Socialist government since it came to power in 1982, faces major obstacles to his goal of modernizing the country's administrative machinery in science.

His first challenge is to define which areas will be included in the plan, a project that must be completed before funds can be allocated in next year's budget. One sticking. point has been the slow pace of an intragovernmental panel, drawn from most of the ministries with research activities, that was expected to coordinate overlapping programs.

"We've included more than 100 different projects in the proposal for the country's first space pro gram," noted Jaime Sodupe, Spain's delegate to the European Space Agency. "Yet many of these surely overlap with ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies